Search results
Results from the WOW.Com Content Network
The pharmaceutical industry in Pakistan was estimated to be worth Rs. 748 billion (US$2.6 billion) in 2023, representing about 1% of the country's GDP. [1] The industry is largely import-dependent, with more than 90% of raw material being imported and only 12% of active pharmaceutical ingredients locally produced. [1]
Brooks Pharmacy was the main trade name for The Jean Coutu Group (PJC) USA, Inc., which was formerly the U.S. subsidiary of the Quebec-based Jean Coutu Group, ...
According to the Economic complexity index, Pakistan is the 67th largest export economy in the world and the 106th most complex economy. [10] During the fiscal year 2015–16, Pakistan's exports stood at US$20.81 billion and imports at US$44.76 billion, resulting in a negative trade balance of US$23.96 billion.
Pakistan portal; Pages in category "Pharmaceutical companies of Pakistan" The following 4 pages are in this category, out of 4 total.
A reescalating battle between pharmaceutical companies and pharmacy benefit managers is brewing in Washington, D.C., as President Donald Trump's new administration takes shape. The drug industry's ...
The United States imported more than $176 billion of pharmaceutical products from overseas in 2023, close to $6 billion of which came from China, according to U.S. trade data.
In 2010, Martin Dow acquired the manufacturing facility and brands of Roche Pakistan. [8] In 2015, Martin Dow was recognized as a Global Growth Company by the World Economic Forum. [9] In the same year, Martin Dow entered into an alliance with Biocodex S.A., a France-based pharmaceutical company. [10]
GSK Pakistan equation was formed when Beecham, Glaxo Welcome and Smith Kline, all having a big name in the pharmaceutical market and that were separate entities before, merged in 2002. [4] In December 2008, GSK Pakistan acquired operations of Bristol Myers Squibb in Pakistan for approximately US$36.5 million. [5]